Global Endocrinology and Metabolism Market Outlook , 2030

2024

Global Endocrinology and Metabolism Market Outlook , 2030

Name: Global Endocrinology and Metabolism Market Outlook , 2030
Brand: Bonafide Research
SKU: 95001079
Price: 3450 USD
Availability: InStock
Rating: 5 (12.6 reviews)

The Global Endocrinology and Metabolism Market is set to exceed $181.3 billion by 2030, driven by rigorous drug development processes and stringent safety assessments.

Bonafide Trust
10-07-2024
Pages : 108
Figures : 78
Tables : 106
Region : Global
Category : Lifescience & Healthcare
Healthcare

Schedule a Call

Buy Now Get Free sample

Request new version

Request for updated version of the report at the same price

Order Now

The global endocrinology and metabolism market encompasses a vast array of products and services aimed at managing and treating hormonal imbalances and metabolic disorders. It includes pharmaceuticals, medical devices, diagnostic tools, and healthcare services. The market is driven by the increasing prevalence of chronic diseases such as diabetes, obesity, and thyroid disorders, as well as advancements in medical technology and research. The complexity of endocrine and metabolic conditions necessitates a comprehensive approach to treatment, involving a combination of medications, lifestyle modifications, and patient education. While the global endocrinology and metabolism market shares certain commonalities, it also exhibits distinct characteristics across different regions. The incidence and prevalence of endocrine diseases vary significantly based on factors such as diet, lifestyle, and genetic predisposition. For instance, the prevalence of type 2 diabetes is higher in countries with high rates of obesity and sedentary lifestyles. Additionally, healthcare infrastructure and access to specialized care differ across regions, impacting the availability and affordability of treatment options. The regulatory landscape for pharmaceutical and medical device approvals also varies, influencing the introduction of new products and therapies. Furthermore, cultural and societal attitudes towards chronic diseases play a role in patient awareness, seeking medical care, and adherence to treatment plans.

According to the research report, “Global Endocrinology and Metabolism Market Outlook, 2030” published by Bonafide Research, the market is anticipated to cross US$ 181310 million in 2030 increasing from US$ 93810 million in 2024. Drug development and approval processes are stringent, requiring extensive clinical trials and safety assessments. Medical devices and diagnostic tools are subject to similar regulatory oversight. Additionally, data privacy and patient confidentiality regulations are crucial for protecting sensitive medical information. While these regulations ensure patient safety, they also increase the time and cost associated with product development and market entry. Opportunities for growth in the endocrinology and metabolism market lie in the development of innovative therapies, personalized medicine, and digital health solutions. Academic conferences, medical congresses, and industry events serve as platforms for knowledge sharing, collaboration, and networking. However, the market is also characterized by intense competition, with pharmaceutical companies and medical device manufacturers investing heavily in research and development to gain a competitive edge. Pricing in the endocrinology and metabolism market is influenced by factors such as research and development costs, manufacturing expenses, and market competition. The pricing of therapeutic drugs is often subject to government price controls and reimbursement policies, which can impact profitability. Medical devices and diagnostic tools typically have higher price points due to technological complexity and specialized manufacturing processes. The availability of generic alternatives and biosimilars can also influence pricing dynamics.

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample

Market Dynamics
Market Drivers
Aging Population and Chronic Disease Burden: The aging population is experiencing a higher incidence of chronic endocrine and metabolic diseases. This demographic shift is driving the demand for effective management and treatment options. The increasing healthcare expenditure on chronic disease management is also contributing to market growth.
Technological Advancements and Innovation: Breakthroughs in medical technology are revolutionizing the diagnosis and treatment of endocrine disorders. The development of advanced diagnostic tools, such as continuous glucose monitoring systems and point-of-care testing devices, is improving disease management. Additionally, innovations in drug delivery systems and therapeutic modalities are expanding treatment options.
Rising Healthcare Expenditure and Increased Access: The increasing allocation of healthcare budgets to chronic disease management is driving market growth. Developing countries are also witnessing a rise in healthcare expenditure, leading to improved access to endocrine care. These factors are creating opportunities for the development and commercialization of innovative products and services.
Market Challenges
• High Cost of Drug Development: Developing novel therapies for endocrine disorders is a complex and expensive process. The high cost of clinical trials, regulatory hurdles, and market access challenges can hinder drug development and commercialization. This can limit the availability of affordable treatment options for patients.
•
• Access to Care Disparities: Ensuring patient adherence to complex treatment regimens is a significant challenge in managing chronic endocrine diseases. Factors such as lifestyle modifications, medication compliance, and patient education play a crucial role in achieving optimal outcomes. Addressing these challenges requires a multidisciplinary approach.
•
• Access to Care Disparities: Access to quality endocrine care varies widely across different regions and socioeconomic groups. Disparities in healthcare infrastructure, healthcare providers, and patient education can hinder early diagnosis and treatment. Addressing these disparities is essential to improve patient outcomes and reduce the burden of endocrine diseases.
Market Trends
Personalized Medicine and Precision Endocrinology: The landscape of endocrinology and metabolism is undergoing a transformative shift towards personalized medicine. Advancements in genomics, proteomics, and metabolomics are enabling tailored treatment approaches for patients with endocrine disorders. This trend is driving the development of diagnostic tools, biomarkers, and targeted therapies, promising to improve patient outcomes and reduce adverse effects.
Increasing Prevalence of Metabolic Disorders: The global surge in obesity, type 2 diabetes, and metabolic syndrome is a major driver of growth in the endocrinology and metabolism market. Changing dietary habits, sedentary lifestyles, and aging populations are contributing to this epidemic. The rising prevalence of these conditions is increasing the demand for preventive care, diagnostic tools, and therapeutic interventions.
Focus on Rare Endocrine Disorders: While common endocrine disorders like diabetes and thyroid diseases receive significant attention, the market is also witnessing a growing focus on rare endocrine conditions. Advances in genetic research and diagnostic capabilities are leading to increased awareness and diagnosis of these disorders. This trend is driving the development of orphan drugs and specialized care pathways.
•
Segmentation Analysis
Diabetes drugs lead in the Global Endocrinology and Metabolism Market due to the increasing prevalence of diabetes, particularly Type 2 diabetes, and the growing demand for effective treatment options.
The global endocrinology and metabolism market is segmented by type into diabetes drugs, human growth hormone (HGH), thyroid hormone disorders, and others. Among these, diabetes drugs constitute the most substantial segment, driven by the escalating prevalence of diabetes worldwide. The increasing incidence of both type 1 and type 2 diabetes, primarily attributed to sedentary lifestyles, urbanization, and dietary changes, has fueled the demand for a wide range of diabetes medications. This segment encompasses insulin, oral hypoglycemic agents, and incretin-based therapies. Insulin remains a cornerstone treatment for type 1 diabetes, while oral medications like metformin and sulfonylureas are widely used for type 2 diabetes management. The emergence of newer drug classes, such as dipeptidyl peptidase-4 (DPP-4) inhibitors, glucagon-like peptide-1 (GLP-1) receptor agonists, and sodium-glucose co-transporter-2 (SGLT2) inhibitors, has expanded treatment options and improved diabetes care. The focus on developing combination therapies and personalized medicine approaches further underscores the dynamic nature of the diabetes drug market. While HGH, thyroid hormone disorders, and other segments contribute to the overall market, they are relatively smaller in comparison to diabetes drugs and exhibit specific growth trajectories influenced by factors such as disease prevalence, therapeutic advancements, and patient demographics.

Hospital pharmacies lead in the Global Endocrinology and Metabolism Market due to their direct access to patients and the ability to provide comprehensive medication management and counseling.

The Endocrinology and Metabolism market is significantly influenced by the distribution channel through which medications are accessed. Hospital pharmacies, traditionally the primary outlet, continue to play a crucial role in dispensing specialized medications and providing expert advice to patients with chronic conditions. However, the landscape is evolving rapidly. Retail pharmacies, with their widespread accessibility and over-the-counter offerings, have gained prominence in the market. They serve as convenient points for patients to procure essential medications, particularly for conditions that require long-term management. Moreover, the integration of technology has propelled the growth of online pharmacies, offering patients the convenience of home delivery and access to a wider range of products. While hospital pharmacies retain a stronghold in dispensing complex and specialized medications, retail pharmacies benefit from higher foot traffic and impulse purchases. Online pharmacies are rapidly gaining traction due to their convenience, competitive pricing, and the ability to reach a broader customer base. The optimal distribution channel often depends on factors such as medication type, patient preference, geographic location, and healthcare infrastructure.

Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Sikandar Kesari

Research Analyst

Regional Analysis
North America leads in the Flip Chip market due to its advanced healthcare infrastructure, research capabilities, and high prevalence of endocrine disorders.
North America stands as the leading region in the global endocrinology and metabolism market, driven by several key factors. The region boasts a well-established healthcare infrastructure, with advanced research institutions, world-class hospitals, and a skilled workforce of healthcare professionals. This enables early detection and treatment of endocrine disorders, leading to better patient outcomes. Additionally, North America has a strong pharmaceutical industry, which has invested significantly in research and development of innovative therapies for endocrine diseases. This has resulted in a robust pipeline of new drugs and treatment options, further solidifying the region's position as a leader in the market. Furthermore, the North American population faces a high prevalence of endocrine disorders, such as diabetes, thyroid diseases, and obesity. This demographic factor, coupled with increased awareness and improved access to healthcare, has driven demand for endocrinology and metabolism services. The region's strong healthcare insurance coverage also plays a crucial role in enabling patients to seek necessary treatments and medications.

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Endocrinology and Metabolism Market Size 2019-2030
2.1.2 Endocrinology and Metabolism Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Endocrinology and Metabolism by Country/Region, 2019, 2023 & 2030
2.2 Endocrinology and Metabolism Segment by Type
2.2.1 Diabetes Drugs
2.2.2 HGH
2.2.3 Thyroid Hormone Disorders
2.2.4 Others
2.3 Endocrinology and Metabolism Market Size by Type
2.3.1 Endocrinology and Metabolism Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Endocrinology and Metabolism Market Size Market Share by Type (2019-2024)
2.4 Endocrinology and Metabolism Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Endocrinology and Metabolism Market Size by Application
2.5.1 Endocrinology and Metabolism Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Endocrinology and Metabolism Market Size Market Share by Application (2019-2024)
3 Endocrinology and Metabolism Market Size by Player
3.1 Endocrinology and Metabolism Market Size Market Share by Player
3.1.1 Global Endocrinology and Metabolism Revenue by Player (2019-2024)
3.1.2 Global Endocrinology and Metabolism Revenue Market Share by Player (2019-2024)
3.2 Global Endocrinology and Metabolism Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Endocrinology and Metabolism by Region
4.1 Endocrinology and Metabolism Market Size by Region (2019-2024)
4.2 Global Endocrinology and Metabolism Annual Revenue by Country/Region (2019-2024)
4.3 Americas Endocrinology and Metabolism Market Size Growth (2019-2024)
4.4 APAC Endocrinology and Metabolism Market Size Growth (2019-2024)
4.5 Europe Endocrinology and Metabolism Market Size Growth (2019-2024)
4.6 Middle East & Africa Endocrinology and Metabolism Market Size Growth (2019-2024)
5 Americas
5.1 Americas Endocrinology and Metabolism Market Size by Country (2019-2024)
5.2 Americas Endocrinology and Metabolism Market Size by Type (2019-2024)
5.3 Americas Endocrinology and Metabolism Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Endocrinology and Metabolism Market Size by Region (2019-2024)
6.2 APAC Endocrinology and Metabolism Market Size by Type (2019-2024)
6.3 APAC Endocrinology and Metabolism Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Endocrinology and Metabolism Market Size by Country (2019-2024)
7.2 Europe Endocrinology and Metabolism Market Size by Type (2019-2024)
7.3 Europe Endocrinology and Metabolism Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Endocrinology and Metabolism by Region (2019-2024)
8.2 Middle East & Africa Endocrinology and Metabolism Market Size by Type (2019-2024)
8.3 Middle East & Africa Endocrinology and Metabolism Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Endocrinology and Metabolism Market Forecast
10.1 Global Endocrinology and Metabolism Forecast by Region (2025-2030)
10.1.1 Global Endocrinology and Metabolism Forecast by Region (2025-2030)
10.1.2 Americas Endocrinology and Metabolism Forecast
10.1.3 APAC Endocrinology and Metabolism Forecast
10.1.4 Europe Endocrinology and Metabolism Forecast
10.1.5 Middle East & Africa Endocrinology and Metabolism Forecast
10.2 Americas Endocrinology and Metabolism Forecast by Country (2025-2030)
10.2.1 United States Market Endocrinology and Metabolism Forecast
10.2.2 Canada Market Endocrinology and Metabolism Forecast
10.2.3 Mexico Market Endocrinology and Metabolism Forecast
10.2.4 Brazil Market Endocrinology and Metabolism Forecast
10.3 APAC Endocrinology and Metabolism Forecast by Region (2025-2030)
10.3.1 China Endocrinology and Metabolism Market Forecast
10.3.2 Japan Market Endocrinology and Metabolism Forecast
10.3.3 Korea Market Endocrinology and Metabolism Forecast
10.3.4 Southeast Asia Market Endocrinology and Metabolism Forecast
10.3.5 India Market Endocrinology and Metabolism Forecast
10.3.6 Australia Market Endocrinology and Metabolism Forecast
10.4 Europe Endocrinology and Metabolism Forecast by Country (2025-2030)
10.4.1 Germany Market Endocrinology and Metabolism Forecast
10.4.2 France Market Endocrinology and Metabolism Forecast
10.4.3 UK Market Endocrinology and Metabolism Forecast
10.4.4 Italy Market Endocrinology and Metabolism Forecast
10.4.5 Russia Market Endocrinology and Metabolism Forecast
10.5 Middle East & Africa Endocrinology and Metabolism Forecast by Region (2025-2030)
10.5.1 Egypt Market Endocrinology and Metabolism Forecast
10.5.2 South Africa Market Endocrinology and Metabolism Forecast
10.5.3 Israel Market Endocrinology and Metabolism Forecast
10.5.4 Turkey Market Endocrinology and Metabolism Forecast
10.6 Global Endocrinology and Metabolism Forecast by Type (2025-2030)
10.7 Global Endocrinology and Metabolism Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Endocrinology and Metabolism Forecast
11 Key Players Analysis
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Information
11.1.2 Abbott Laboratories Endocrinology and Metabolism Product Offered
11.1.3 Abbott Laboratories Endocrinology and Metabolism Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Abbott Laboratories Main Business Overview
11.1.5 Abbott Laboratories Latest Developments
11.2 Acerus Pharmaceuticals Corp.
11.2.1 Acerus Pharmaceuticals Corp. Company Information
11.2.2 Acerus Pharmaceuticals Corp. Endocrinology and Metabolism Product Offered
11.2.3 Acerus Pharmaceuticals Corp. Endocrinology and Metabolism Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Acerus Pharmaceuticals Corp. Main Business Overview
11.2.5 Acerus Pharmaceuticals Corp. Latest Developments
11.3 Ascendis Pharma AS
11.3.1 Ascendis Pharma AS Company Information
11.3.2 Ascendis Pharma AS Endocrinology and Metabolism Product Offered
11.3.3 Ascendis Pharma AS Endocrinology and Metabolism Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Ascendis Pharma AS Main Business Overview
11.3.5 Ascendis Pharma AS Latest Developments
11.4 Bayer AG
11.4.1 Bayer AG Company Information
11.4.2 Bayer AG Endocrinology and Metabolism Product Offered
11.4.3 Bayer AG Endocrinology and Metabolism Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Bayer AG Main Business Overview
11.4.5 Bayer AG Latest Developments
11.5 Beta Cell NV
11.5.1 Beta Cell NV Company Information
11.5.2 Beta Cell NV Endocrinology and Metabolism Product Offered
11.5.3 Beta Cell NV Endocrinology and Metabolism Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Beta Cell NV Main Business Overview
11.5.5 Beta Cell NV Latest Developments
11.6 Biocon Ltd.
11.6.1 Biocon Ltd. Company Information
11.6.2 Biocon Ltd. Endocrinology and Metabolism Product Offered
11.6.3 Biocon Ltd. Endocrinology and Metabolism Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Biocon Ltd. Main Business Overview
11.6.5 Biocon Ltd. Latest Developments
11.7 Eli Lilly and Co.
11.7.1 Eli Lilly and Co. Company Information
11.7.2 Eli Lilly and Co. Endocrinology and Metabolism Product Offered
11.7.3 Eli Lilly and Co. Endocrinology and Metabolism Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Eli Lilly and Co. Main Business Overview
11.7.5 Eli Lilly and Co. Latest Developments
11.8 Endo International Plc
11.8.1 Endo International Plc Company Information
11.8.2 Endo International Plc Endocrinology and Metabolism Product Offered
11.8.3 Endo International Plc Endocrinology and Metabolism Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Endo International Plc Main Business Overview
11.8.5 Endo International Plc Latest Developments
11.9 Hoffmann La Roche Ltd.
11.9.1 Hoffmann La Roche Ltd. Company Information
11.9.2 Hoffmann La Roche Ltd. Endocrinology and Metabolism Product Offered
11.9.3 Hoffmann La Roche Ltd. Endocrinology and Metabolism Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Hoffmann La Roche Ltd. Main Business Overview
11.9.5 Hoffmann La Roche Ltd. Latest Developments
11.10 GlaxoSmithKline Plc
11.10.1 GlaxoSmithKline Plc Company Information
11.10.2 GlaxoSmithKline Plc Endocrinology and Metabolism Product Offered
11.10.3 GlaxoSmithKline Plc Endocrinology and Metabolism Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 GlaxoSmithKline Plc Main Business Overview
11.10.5 GlaxoSmithKline Plc Latest Developments
11.11 Hanmi Pharm Co. Ltd.
11.11.1 Hanmi Pharm Co. Ltd. Company Information
11.11.2 Hanmi Pharm Co. Ltd. Endocrinology and Metabolism Product Offered
11.11.3 Hanmi Pharm Co. Ltd. Endocrinology and Metabolism Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Hanmi Pharm Co. Ltd. Main Business Overview
11.11.5 Hanmi Pharm Co. Ltd. Latest Developments
11.12 Ipsen Pharma
11.12.1 Ipsen Pharma Company Information
11.12.2 Ipsen Pharma Endocrinology and Metabolism Product Offered
11.12.3 Ipsen Pharma Endocrinology and Metabolism Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Ipsen Pharma Main Business Overview
11.12.5 Ipsen Pharma Latest Developments
12 Research Findings and Conclusion

List of Tables
Table 1. Endocrinology and Metabolism Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Endocrinology and Metabolism Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Diabetes Drugs
Table 4. Major Players of HGH
Table 5. Major Players of Thyroid Hormone Disorders
Table 6. Major Players of Others
Table 7. Endocrinology and Metabolism Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 8. Global Endocrinology and Metabolism Market Size by Type (2019-2024) & ($ millions)
Table 9. Global Endocrinology and Metabolism Market Size Market Share by Type (2019-2024)
Table 10. Endocrinology and Metabolism Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 11. Global Endocrinology and Metabolism Market Size by Application (2019-2024) & ($ millions)
Table 12. Global Endocrinology and Metabolism Market Size Market Share by Application (2019-2024)
Table 13. Global Endocrinology and Metabolism Revenue by Player (2019-2024) & ($ millions)
Table 14. Global Endocrinology and Metabolism Revenue Market Share by Player (2019-2024)
Table 15. Endocrinology and Metabolism Key Players Head office and Products Offered
Table 16. Endocrinology and Metabolism Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Endocrinology and Metabolism Market Size by Region (2019-2024) & ($ millions)
Table 20. Global Endocrinology and Metabolism Market Size Market Share by Region (2019-2024)
Table 21. Global Endocrinology and Metabolism Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global Endocrinology and Metabolism Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas Endocrinology and Metabolism Market Size by Country (2019-2024) & ($ millions)
Table 24. Americas Endocrinology and Metabolism Market Size Market Share by Country (2019-2024)
Table 25. Americas Endocrinology and Metabolism Market Size by Type (2019-2024) & ($ millions)
Table 26. Americas Endocrinology and Metabolism Market Size Market Share by Type (2019-2024)
Table 27. Americas Endocrinology and Metabolism Market Size by Application (2019-2024) & ($ millions)
Table 28. Americas Endocrinology and Metabolism Market Size Market Share by Application (2019-2024)
Table 29. APAC Endocrinology and Metabolism Market Size by Region (2019-2024) & ($ millions)
Table 30. APAC Endocrinology and Metabolism Market Size Market Share by Region (2019-2024)
Table 31. APAC Endocrinology and Metabolism Market Size by Type (2019-2024) & ($ millions)
Table 32. APAC Endocrinology and Metabolism Market Size by Application (2019-2024) & ($ millions)
Table 33. Europe Endocrinology and Metabolism Market Size by Country (2019-2024) & ($ millions)
Table 34. Europe Endocrinology and Metabolism Market Size Market Share by Country (2019-2024)
Table 35. Europe Endocrinology and Metabolism Market Size by Type (2019-2024) & ($ millions)
Table 36. Europe Endocrinology and Metabolism Market Size by Application (2019-2024) & ($ millions)
Table 37. Middle East & Africa Endocrinology and Metabolism Market Size by Region (2019-2024) & ($ millions)
Table 38. Middle East & Africa Endocrinology and Metabolism Market Size by Type (2019-2024) & ($ millions)
Table 39. Middle East & Africa Endocrinology and Metabolism Market Size by Application (2019-2024) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Endocrinology and Metabolism
Table 41. Key Market Challenges & Risks of Endocrinology and Metabolism
Table 42. Key Industry Trends of Endocrinology and Metabolism
Table 43. Global Endocrinology and Metabolism Market Size Forecast by Region (2025-2030) & ($ millions)
Table 44. Global Endocrinology and Metabolism Market Size Market Share Forecast by Region (2025-2030)
Table 45. Global Endocrinology and Metabolism Market Size Forecast by Type (2025-2030) & ($ millions)
Table 46. Global Endocrinology and Metabolism Market Size Forecast by Application (2025-2030) & ($ millions)
Table 47. Abbott Laboratories Details, Company Type, Endocrinology and Metabolism Area Served and Its Competitors
Table 48. Abbott Laboratories Endocrinology and Metabolism Product Offered
Table 49. Abbott Laboratories Endocrinology and Metabolism Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 50. Abbott Laboratories Main Business
Table 51. Abbott Laboratories Latest Developments
Table 52. Acerus Pharmaceuticals Corp. Details, Company Type, Endocrinology and Metabolism Area Served and Its Competitors
Table 53. Acerus Pharmaceuticals Corp. Endocrinology and Metabolism Product Offered
Table 54. Acerus Pharmaceuticals Corp. Endocrinology and Metabolism Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Acerus Pharmaceuticals Corp. Main Business
Table 56. Acerus Pharmaceuticals Corp. Latest Developments
Table 57. Ascendis Pharma AS Details, Company Type, Endocrinology and Metabolism Area Served and Its Competitors
Table 58. Ascendis Pharma AS Endocrinology and Metabolism Product Offered
Table 59. Ascendis Pharma AS Endocrinology and Metabolism Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Ascendis Pharma AS Main Business
Table 61. Ascendis Pharma AS Latest Developments
Table 62. Bayer AG Details, Company Type, Endocrinology and Metabolism Area Served and Its Competitors
Table 63. Bayer AG Endocrinology and Metabolism Product Offered
Table 64. Bayer AG Endocrinology and Metabolism Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Bayer AG Main Business
Table 66. Bayer AG Latest Developments
Table 67. Beta Cell NV Details, Company Type, Endocrinology and Metabolism Area Served and Its Competitors
Table 68. Beta Cell NV Endocrinology and Metabolism Product Offered
Table 69. Beta Cell NV Endocrinology and Metabolism Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Beta Cell NV Main Business
Table 71. Beta Cell NV Latest Developments
Table 72. Biocon Ltd. Details, Company Type, Endocrinology and Metabolism Area Served and Its Competitors
Table 73. Biocon Ltd. Endocrinology and Metabolism Product Offered
Table 74. Biocon Ltd. Endocrinology and Metabolism Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Biocon Ltd. Main Business
Table 76. Biocon Ltd. Latest Developments
Table 77. Eli Lilly and Co. Details, Company Type, Endocrinology and Metabolism Area Served and Its Competitors
Table 78. Eli Lilly and Co. Endocrinology and Metabolism Product Offered
Table 79. Eli Lilly and Co. Endocrinology and Metabolism Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Eli Lilly and Co. Main Business
Table 81. Eli Lilly and Co. Latest Developments
Table 82. Endo International Plc Details, Company Type, Endocrinology and Metabolism Area Served and Its Competitors
Table 83. Endo International Plc Endocrinology and Metabolism Product Offered
Table 84. Endo International Plc Endocrinology and Metabolism Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Endo International Plc Main Business
Table 86. Endo International Plc Latest Developments
Table 87. Hoffmann La Roche Ltd. Details, Company Type, Endocrinology and Metabolism Area Served and Its Competitors
Table 88. Hoffmann La Roche Ltd. Endocrinology and Metabolism Product Offered
Table 89. Hoffmann La Roche Ltd. Endocrinology and Metabolism Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Hoffmann La Roche Ltd. Main Business
Table 91. Hoffmann La Roche Ltd. Latest Developments
Table 92. GlaxoSmithKline Plc Details, Company Type, Endocrinology and Metabolism Area Served and Its Competitors
Table 93. GlaxoSmithKline Plc Endocrinology and Metabolism Product Offered
Table 94. GlaxoSmithKline Plc Endocrinology and Metabolism Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. GlaxoSmithKline Plc Main Business
Table 96. GlaxoSmithKline Plc Latest Developments
Table 97. Hanmi Pharm Co. Ltd. Details, Company Type, Endocrinology and Metabolism Area Served and Its Competitors
Table 98. Hanmi Pharm Co. Ltd. Endocrinology and Metabolism Product Offered
Table 99. Hanmi Pharm Co. Ltd. Endocrinology and Metabolism Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Hanmi Pharm Co. Ltd. Main Business
Table 101. Hanmi Pharm Co. Ltd. Latest Developments
Table 102. Ipsen Pharma Details, Company Type, Endocrinology and Metabolism Area Served and Its Competitors
Table 103. Ipsen Pharma Endocrinology and Metabolism Product Offered
Table 104. Ipsen Pharma Endocrinology and Metabolism Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 105. Ipsen Pharma Main Business
Table 106. Ipsen Pharma Latest Developments

List of Figures
Figure 1. Endocrinology and Metabolism Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Endocrinology and Metabolism Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Endocrinology and Metabolism Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Endocrinology and Metabolism Sales Market Share by Country/Region (2023)
Figure 8. Endocrinology and Metabolism Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Endocrinology and Metabolism Market Size Market Share by Type in 2023
Figure 10. Endocrinology and Metabolism in Hospital Pharmacies
Figure 11. Global Endocrinology and Metabolism Market: Hospital Pharmacies (2019-2024) & ($ millions)
Figure 12. Endocrinology and Metabolism in Retail Pharmacies
Figure 13. Global Endocrinology and Metabolism Market: Retail Pharmacies (2019-2024) & ($ millions)
Figure 14. Endocrinology and Metabolism in Online Pharmacies
Figure 15. Global Endocrinology and Metabolism Market: Online Pharmacies (2019-2024) & ($ millions)
Figure 16. Global Endocrinology and Metabolism Market Size Market Share by Application in 2023
Figure 17. Global Endocrinology and Metabolism Revenue Market Share by Player in 2023
Figure 18. Global Endocrinology and Metabolism Market Size Market Share by Region (2019-2024)
Figure 19. Americas Endocrinology and Metabolism Market Size 2019-2024 ($ millions)
Figure 20. APAC Endocrinology and Metabolism Market Size 2019-2024 ($ millions)
Figure 21. Europe Endocrinology and Metabolism Market Size 2019-2024 ($ millions)
Figure 22. Middle East & Africa Endocrinology and Metabolism Market Size 2019-2024 ($ millions)
Figure 23. Americas Endocrinology and Metabolism Value Market Share by Country in 2023
Figure 24. United States Endocrinology and Metabolism Market Size Growth 2019-2024 ($ millions)
Figure 25. Canada Endocrinology and Metabolism Market Size Growth 2019-2024 ($ millions)
Figure 26. Mexico Endocrinology and Metabolism Market Size Growth 2019-2024 ($ millions)
Figure 27. Brazil Endocrinology and Metabolism Market Size Growth 2019-2024 ($ millions)
Figure 28. APAC Endocrinology and Metabolism Market Size Market Share by Region in 2023
Figure 29. APAC Endocrinology and Metabolism Market Size Market Share by Type (2019-2024)
Figure 30. APAC Endocrinology and Metabolism Market Size Market Share by Application (2019-2024)
Figure 31. China Endocrinology and Metabolism Market Size Growth 2019-2024 ($ millions)
Figure 32. Japan Endocrinology and Metabolism Market Size Growth 2019-2024 ($ millions)
Figure 33. South Korea Endocrinology and Metabolism Market Size Growth 2019-2024 ($ millions)
Figure 34. Southeast Asia Endocrinology and Metabolism Market Size Growth 2019-2024 ($ millions)
Figure 35. India Endocrinology and Metabolism Market Size Growth 2019-2024 ($ millions)
Figure 36. Australia Endocrinology and Metabolism Market Size Growth 2019-2024 ($ millions)
Figure 37. Europe Endocrinology and Metabolism Market Size Market Share by Country in 2023
Figure 38. Europe Endocrinology and Metabolism Market Size Market Share by Type (2019-2024)
Figure 39. Europe Endocrinology and Metabolism Market Size Market Share by Application (2019-2024)
Figure 40. Germany Endocrinology and Metabolism Market Size Growth 2019-2024 ($ millions)
Figure 41. France Endocrinology and Metabolism Market Size Growth 2019-2024 ($ millions)
Figure 42. UK Endocrinology and Metabolism Market Size Growth 2019-2024 ($ millions)
Figure 43. Italy Endocrinology and Metabolism Market Size Growth 2019-2024 ($ millions)
Figure 44. Russia Endocrinology and Metabolism Market Size Growth 2019-2024 ($ millions)
Figure 45. Middle East & Africa Endocrinology and Metabolism Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Endocrinology and Metabolism Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Endocrinology and Metabolism Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Endocrinology and Metabolism Market Size Growth 2019-2024 ($ millions)
Figure 49. South Africa Endocrinology and Metabolism Market Size Growth 2019-2024 ($ millions)
Figure 50. Israel Endocrinology and Metabolism Market Size Growth 2019-2024 ($ millions)
Figure 51. Turkey Endocrinology and Metabolism Market Size Growth 2019-2024 ($ millions)
Figure 52. GCC Countries Endocrinology and Metabolism Market Size Growth 2019-2024 ($ millions)
Figure 53. Americas Endocrinology and Metabolism Market Size 2025-2030 ($ millions)
Figure 54. APAC Endocrinology and Metabolism Market Size 2025-2030 ($ millions)
Figure 55. Europe Endocrinology and Metabolism Market Size 2025-2030 ($ millions)
Figure 56. Middle East & Africa Endocrinology and Metabolism Market Size 2025-2030 ($ millions)
Figure 57. United States Endocrinology and Metabolism Market Size 2025-2030 ($ millions)
Figure 58. Canada Endocrinology and Metabolism Market Size 2025-2030 ($ millions)
Figure 59. Mexico Endocrinology and Metabolism Market Size 2025-2030 ($ millions)
Figure 60. Brazil Endocrinology and Metabolism Market Size 2025-2030 ($ millions)
Figure 61. China Endocrinology and Metabolism Market Size 2025-2030 ($ millions)
Figure 62. Japan Endocrinology and Metabolism Market Size 2025-2030 ($ millions)
Figure 63. Korea Endocrinology and Metabolism Market Size 2025-2030 ($ millions)
Figure 64. Southeast Asia Endocrinology and Metabolism Market Size 2025-2030 ($ millions)
Figure 65. India Endocrinology and Metabolism Market Size 2025-2030 ($ millions)
Figure 66. Australia Endocrinology and Metabolism Market Size 2025-2030 ($ millions)
Figure 67. Germany Endocrinology and Metabolism Market Size 2025-2030 ($ millions)
Figure 68. France Endocrinology and Metabolism Market Size 2025-2030 ($ millions)
Figure 69. UK Endocrinology and Metabolism Market Size 2025-2030 ($ millions)
Figure 70. Italy Endocrinology and Metabolism Market Size 2025-2030 ($ millions)
Figure 71. Russia Endocrinology and Metabolism Market Size 2025-2030 ($ millions)
Figure 72. Egypt Endocrinology and Metabolism Market Size 2025-2030 ($ millions)
Figure 73. South Africa Endocrinology and Metabolism Market Size 2025-2030 ($ millions)
Figure 74. Israel Endocrinology and Metabolism Market Size 2025-2030 ($ millions)
Figure 75. Turkey Endocrinology and Metabolism Market Size 2025-2030 ($ millions)
Figure 76. GCC Countries Endocrinology and Metabolism Market Size 2025-2030 ($ millions)
Figure 77. Global Endocrinology and Metabolism Market Size Market Share Forecast by Type (2025-2030)
Figure 78. Global Endocrinology and Metabolism Market Size Market Share Forecast by Application (2025-2030)
"

Related Reports

One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information

One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information

Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information

All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information

Safe and Secure SSL Encrypted